[ACCESSWIRE]
MORRISVILLE, NC / ACCESSWIRE / March 20, 2017 / Tenax Therapeutics, Inc. (NASDAQ: TENX) will host a conference call and webcast to discuss the results of the fiscal year 2016, to be held Tuesday, March 21, 2017 at 8:30 AM Eastern Time.
Live Event Information
To participate, connect approximately 5 to 10 minutes before the beginning of the event.
A webcast replay will be available for three months, beginning approximately 2 hours after the completion of the live event.
About Tenax Therapeutics
Tenax Therapeutics, Inc., is a specialty pharmaceutical company focused on identifying, developing and commercializing products for the critical care market. The Company owns the North American rights to develop and commercialize levosimendan, a novel, first in class calcium sensitizer/K-ATP activator. For more information, visit www.tenaxthera.com.
SOURCE: Investor Network
